Peptide Atlas · Peptide

Bremelanotide

Bremelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone with high affinity for the melanocortin-4 receptor.

established

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Bremelanotide' with aliases PT-141, Vyleesi · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
fact added identity: PubChem CID 9941379: Bremelanotide, C50H68N14O10, 1025.2 g/mol. · 2026-09-27 04:00 · somebody
fact added identity: CAS registry number 189691-06-3. · 2026-09-27 04:00 · somebody
fact added identity: IUPAC name: (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-1 · 2026-09-27 04:00 · somebody
fact added summary: Bremelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone with high affinity for the melanoc · 2026-09-27 04:00 · somebody
fact added history: It was approved in the USA in 2019 as an on-demand subcutaneous therapy for premenopausal women with acquired, generaliz · 2026-09-27 04:00 · somebody
fact added history: In two phase 3 trials randomizing 1,267 women, it increased desire scores and reduced related distress compared with pla · 2026-09-27 04:00 · somebody
citation added pmid 31429064 cited as established: First approval (USA, 2019); melanocortin-4 receptor agonist · 2026-09-27 04:00 · somebody
citation added pmid 31599840 cited as established: Two randomized phase 3 trials (RECONNECT) · 2026-09-27 04:00 · somebody

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.